Pricing Log in Create free account

Pliant Therapeutics, Inc. (PLRX) vs Tenax Therapeutics, Inc. (TENX)

Pliant Therapeutics, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Pliant Therapeutics, Inc. and Tenax Therapeutics, Inc. are of similar size ($60.2M and $56.5M). Pliant Therapeutics, Inc. grew revenue faster over the last twelve months: −49.0% against −70.8%. Across the 12 metrics below, Pliant Therapeutics, Inc. leads on 7 and Tenax Therapeutics, Inc. on 5.

Valuation

Metric PLRX TENX Biotechnology median
P/E n/m n/m 8.50
P/S 11.09 201.11 9.71
P/B 0.38 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.76 0.71 0.64
EV/Sales (14.31) (141.75) 9.21
Earnings yield (165.56%) (108.82%) (33.15%)
Free cash flow yield (126.73%) (66.58%) (25.50%)

Profitability

Metric PLRX TENX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.29%) (59.80%) (56.36%)
Return on assets (37.69%) (57.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PLRX TENX Biotechnology median
Revenue growth (TTM) (48.95%) (70.77%) 6.02%
EPS growth (last fiscal year) 29.97% (16.52%) 30.26%
Revenue growth, 5-year CAGR — 0.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLRX TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.90 15.07 4.72
Net debt to EBITDA 1.27 1.73 0.96

Dividend

Metric PLRX TENX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PLRX TENX Biotechnology median
Market cap 60.21m 56.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack